Remanded
EB-1C
EB-1C Remanded — Pharmaceuticals / Medical Devices (2020): the Director's decision was withdrawn because the analysis
Decision Summary
The Director's decision was withdrawn because the analysis was flawed and did not provide the Petitioner a fair opportunity to contest the findings. However, the AAO found sufficient anomalies and inconsistencies regarding the qualifying relationship, the beneficiary's foreign employment, and the petitioner's ability to pay. Therefore, the case was remanded for further review of these specific issues.
Criteria Discussed
Qualifying Relationship Managerial Or Executive Capacity (Abroad) Managerial Or Executive Capacity (U.S.) Ability To Pay Doing Business Fraud Or Willful Misrepresentation
📄 Original decision (USCIS PDF)
Sign up free to download the original PDF
Downloaded the case? Use it in your next draft →Research more EB-1C decisions on MeritDraft
Browse AAO decisions by visa type, outcome, and criteria discussed.
Browse Decisions →